| Dr Charles Maxwell Weddington, MD | |
|
419 W Redwood St Ste 235, Baltimore, MD 21201-1734 | |
| (405) 501-5781 | |
| Not Available |
| Full Name | Dr Charles Maxwell Weddington |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 419 W Redwood St Ste 235, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003347519 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 125071373 (Illinois) | Secondary |
| 207R00000X | Internal Medicine | 125.071373 (Illinois) | Secondary |
| 207N00000X | Dermatology | D0095080 (Maryland) | Primary |
| Entity Name | University Of Maryland Dermatologists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659304152 PECOS PAC ID: 7810888484 Enrollment ID: O20040323000770 |
News Archive
Scientists in Massachusetts are reporting new evidence that certain high blood pressure drugs may be useful in preventing and treating diabetic retinopathy, the leading cause of vision loss in people with diabetes. The study, the largest to date on proteins in the retina, could lead to new ways to prevent or treat the sight-threatening disease, they say.
The World Health Organization (WHO) and a group of more than 25 partner organizations unveiled a new strategy to fight some of the most neglected tropical diseases that destroy the lives and health of poor people.
Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.
Gamma Medica, a leader in molecular breast imaging technology (MBI), announced today that Southwest X-Ray, the leading outpatient services provider in El Paso, TX, has installed Gamma Medica's LumaGEM Molecular Breast Imaging (MBI) system in its Gateway Blvd.
CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Maxwell Weddington, MD 2160 S 1st Ave, Maywood, IL 60153-3328 Ph: () - | Dr Charles Maxwell Weddington, MD 419 W Redwood St Ste 235, Baltimore, MD 21201-1734 Ph: (405) 501-5781 |
News Archive
Scientists in Massachusetts are reporting new evidence that certain high blood pressure drugs may be useful in preventing and treating diabetic retinopathy, the leading cause of vision loss in people with diabetes. The study, the largest to date on proteins in the retina, could lead to new ways to prevent or treat the sight-threatening disease, they say.
The World Health Organization (WHO) and a group of more than 25 partner organizations unveiled a new strategy to fight some of the most neglected tropical diseases that destroy the lives and health of poor people.
Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.
Gamma Medica, a leader in molecular breast imaging technology (MBI), announced today that Southwest X-Ray, the leading outpatient services provider in El Paso, TX, has installed Gamma Medica's LumaGEM Molecular Breast Imaging (MBI) system in its Gateway Blvd.
CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa.
› Verified 9 days ago
Sarah Nakib, MD, MPH Dermatology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Baltimore, MD 21287 Phone: 410-955-8662 | |
Elizabeth Tanzi, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-6776 | |
Crystal Ugochi Aguh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1550 Orleans St, Crb Ii Room 211, Baltimore, MD 21287 Phone: 410-955-2400 Fax: 410-955-8645 | |
Dr. Larry H Gaston, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2300 Garrison Blvd, Suite 260, Baltimore, MD 21216 Phone: 410-945-7544 Fax: 410-945-3605 | |
Dr. Manisha J. Loss, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Suite 8060b, Baltimore, MD 21287 Phone: 410-502-2082 | |
Dr. Marcia Sanford Driscoll, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 419 W Redwood St, Suite 160, Baltimore, MD 21201 Phone: 410-328-3167 Fax: 410-328-1323 | |
Dr. Myriam Lucia Vega Gonzalez, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St # 8072, Baltimore, MD 21287 Phone: 410-955-5933 Fax: 410-502-2309 |